Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 879658Generated: October 27, 2026

1-(Oxetan-3-yl)piperazine → (S)-methyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-5-methyl-2-(2-(4-(oxetan-3-yl)piperazin-1-yl)pyrimidin-4-yl)benzo[d]thiazol-6-yl)acetate

https://huagongshe.com/reaction/879658

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(Oxetan-3-yl)piperazineHCID 57416287—
Reactant(S)-methyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(2-chloropyrimidin-4-yl)-5-methylbenzo[d]thiazol-6-yl)acetateHCID 86700414—
Solvent1,4-DioxaneHCID 31275—
Product(S)-methyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-5-methyl-2-(2-(4-(oxetan-3-yl)piperazin-1-yl)pyrimidin-4-yl)benzo[d]thiazol-6-yl)acetateHCID 86700471—

Reaction Steps

To (S)-methyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(2-chloropyrimidin-4-yl)-5-methylbenzo[d]thiazol-6-yl)acetate (49.0 mg, 0.095 mmol) was added 1-(oxetan-3-yl)piperazine (27.0 mg, 0.190 mmol) in 1,4-dioxane (1 mL). The reaction mixture was stirred at room temperature for 6 h. Upon completion of the reaction, the reaction mixture was filtered through Celite (ethyl acetate eluent), concentrated, and used without further purification. LCMS-ESI+ calc'd for C32H37ClN5O4S (M+H+): 622.2; Found: 622.2 (M+H+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08987250B2
Source datasetuspto-grants-2015_03
ORD IDord-30d0db471fbb4a18ab5c18bb557f21b3
Source noteuspto-grants-2015_03